These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2498272)

  • 21. Beta-lactam-fosfomycin antagonism involving modification of penicillin-binding protein 3 in Pseudomonas aeruginosa.
    Reguera JA; Baquero F; Berenguer J; Martinez-Ferrer M; Martinez JL
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2093-6. PubMed ID: 2127343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superior effect of tazobactam/piperacillin compared to piperacillin on beta-lactamase-producing Pseudomonas aeruginosa.
    Nishida K; Higashitani F; Hyodo A
    Chemotherapy; 1997; 43(3):171-8. PubMed ID: 9142457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penicillin-binding proteins of Pseudomonas aeruginosa. Comparison of two strains differing in their resistance to beta-lactam antibiotics.
    Curtis NA; Orr D; Boulton MG; Ross GW
    J Antimicrob Chemother; 1981 Feb; 7(2):127-36. PubMed ID: 6783607
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanisms of resistance to beta-lactam antibiotics in Acinetobacter calcoaceticus.
    Obara M; Nakae T
    J Antimicrob Chemother; 1991 Dec; 28(6):791-800. PubMed ID: 1816177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative characteristics of penicillin-binding proteins of representatives of the genus Streptomyces].
    Griaznova NS; Subbotina NA; Beliavskaia IV; Taisova AS; Afonin VI
    Antibiot Khimioter; 1988 Mar; 33(3):223-8. PubMed ID: 3132120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of 5-fluorouracil uptake into the bacterial cell by piperacillin.
    Takahata M; Yamashiro Y; Yotsuji A; Fukuoka Y; Yasuda T; Saikawa I; Ueda Y
    J Antibiot (Tokyo); 1986 Aug; 39(8):1167-71. PubMed ID: 3759666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins.
    Neuwirth C; Siébor E; Duez JM; Péchinot A; Kazmierczak A
    J Antimicrob Chemother; 1995 Aug; 36(2):335-42. PubMed ID: 8522463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PBP binding and periplasmic concentration as determinants of the antibacterial activities of three new oral cephalosporins in Escherichia coli.
    Cornaglia G; Ligozzi M; Bauernfeind A; Satta G; Fontana R
    New Microbiol; 1994 Jul; 17(3):203-10. PubMed ID: 7968655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Actions of beta-lactam antibiotics against Pseudomonas aeruginosa: their effects on penicillin-binding proteins and on bactericidal activity of macrophages].
    Nakamuta S
    Nihon Hinyokika Gakkai Zasshi; 1983 Dec; 74(12):2031-42. PubMed ID: 6429401
    [No Abstract]   [Full Text] [Related]  

  • 31. Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities.
    Cornaglia G; Guan L; Fontana R; Satta G
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1902-8. PubMed ID: 1416880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of two types of Pseudomonas aeruginosa mutants highly sensitive to a specific group of beta-lactam antibiotics and with defect in penicillin-binding proteins.
    Noguchi H; Fukasawa M; Komatsu T; Iyobe S; Mitsuhashi S
    J Antibiot (Tokyo); 1980 Dec; 33(12):1521-6. PubMed ID: 6788742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of resistance to beta-lactam antibiotics with special reference to third-generation cephalosporins.
    Collatz E; Gutmann L; Williamson R; Acar JF
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():13-21. PubMed ID: 6334073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations to the penicillin-binding proteins in the Bacteroides fragilis group: a mechanism for non-beta-lactamase mediated cefoxitin resistance.
    Wexler HM; Halebian S
    J Antimicrob Chemother; 1990 Jul; 26(1):7-20. PubMed ID: 2211448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to beta-lactams in gram-negative bacteria: relative contributions of beta-lactamase and permeability limitations.
    Nayler JH
    J Antimicrob Chemother; 1987 Jun; 19(6):713-32. PubMed ID: 3301784
    [No Abstract]   [Full Text] [Related]  

  • 38. Cefodizime, an aminothiazolylcephalosporin. I. In vitro activity.
    Limbert M; Klesel N; Seeger K; Seibert G; Winkler I; Schrinner E
    J Antibiot (Tokyo); 1984 Aug; 37(8):892-900. PubMed ID: 6090373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance.
    Neu HC; Chin NX
    Chemioterapia; 1985 Feb; 4(1):63-70. PubMed ID: 3872725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
    Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G
    J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.